2014 - 1st XY Congress - Female Cancer Research & Drug Discovery

GTCbio's 1st XY Congress - Female Cancer Research & Drug Discovery to be held on November 6-7, 2014 at the Hyatt Regency Mission Bay in San Diego, CA. This conference offers a unique mix of engaging sessions and topics focused on the research and drug discovery of female specific oncology.
The conference includes keynote addresses from representatives from big pharma, academic institutions and government research labs who will present data and case studies on key topics such as breast cancer diagnostics and therapeutics, clinical advances in female cancer therapy, breast cancer genetics and genomics, Immuno-oncology therapy and targeted therapies in endometrial cancer.
Attend to learn and network with key opinion leaders in a highly interactive and intimate environment, benefiting from the exclusive insights of our faculty of senior industry speakers and renowned topic experts and academia.
2014 Session Topics:
Conference 1: (X Track) Female Cancer Research and Drug Discovery
I. Breast Cancer - Diagnostics and Early Detection
II. Genomics and Breast Cancer
III. Targeting Drug Resistant Pathways
IV. Clinical Advances in Female Cancer Therapy
V. Advances in Ovarian Cancer
General Session (X&Y Tracks)
I. Advances in Gender Neutral Immuno-Oncology Therapy
II. Advances in Gender Neutral Diagnostic/Detection Strategies
III. Clinical Advances in PARP Inhibitors
Sponsorship and exhibiting opportunities are available in a range of levels, which can be tailored to fit your needs. Please contact Amber Kempf 626-256-6405 x110 or amber.kempf-AT-gtcbio.com for more information.